Zurich – DataHow has secured a Series A investment for its artificial intelligence (AI)-based bioprocessing solutions. This funding will enable the company to accelerate its digital bioprocess technology platform DataHowLab.
DataHow has successfully completed a Series A financing round. The Zurich-based company, which was founded in 2017, was able to generate fresh capital for the development and market launch of its digital platform for the development and production of bioprocesses called DataHowLab. The scope of the transaction was not disclosed.
According to a company press release from the spin-off from the Swiss Federal Institute of Technology in Zurich, the round was led by the venture capital firm Momenta from Meggen LU, which focuses on industrial processes. The automation company Rockwell Automation, based in the US state of Wisconsin, and Zürcher Kantonalbank also participated.
"The past few years have underscored the value of flexible and rapid scale-up in bioprocess manufacturing to quickly develop new drugs and compounds to improve the environment and people's quality of life," said Momenta Executive Director Ken Forster. "DataHow is a pioneer in the application of AI models to accelerate the scaling of bioprocess manufacturing."
According to CEO and co-founder Dr. Alessandro Butté, DataHow has sought and found investment partners who understand the impact of digitalization on manufacturing and are deeply rooted in the market, ecosystem, technology and culture. "We have a deep understanding of research and development, but now need partners to help us expand our market and solutions into manufacturing and regulated production environments." ce/mm